Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Alimta

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
On August 19, 2004, pemetrexed for injection (Alimta); Eli Lilly and Company, Indianapolis, IN, http://www.lilly.com) received… Expand
Is this relevant?
Review
2004
Review
2004
  • A. Adjei
  • Clinical Cancer Research
  • 2004
  • Corpus ID: 31467685
Pemetrexed (ALIMTA, LY231514, MTA) is a novel antimetabolite that inhibits at least three enzymes involved in the folate pathway… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The underpinning conceptual model for the Lung Cancer Symptom Scale (LCSS), an instrument used to assess health‐related quality… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Purpose: Raltitrexed, pemetrexed, lometrexol, and ZD9331 are antifolate drugs transported into cells via the ubiquitously… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND The purpose of this study was to evaluate ALIMTA (pemetrexed disodium, LY231514), a multi-targeted antifolate with… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Pemetrexed (ALIMTA, MTA) is a novel thymidylate synthase (TS) inhibitor and has shown activity against colon cancer, mesothelioma… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The purpose of this study was to identify predictive factors for severe toxicity caused by antifolate-chemotherapy using… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND To evaluate the efficacy and safety of pemetrexed therapy for chemotherapy-naïve patients with surgically incurable… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND To evaluate the activity of MTA plus cisplatin in chemotherapy-naive patients with non-small cell lung cancer (NSCLC… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE To determine the safety and activity of LY231514 (ALIMTA, MTA, pemetrexed disodium, Eli Lilly and Co., Indianapolis, IN… Expand
  • table 1
Is this relevant?